{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T18:53:41Z","timestamp":1777056821215,"version":"3.51.4"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.ajog.2019.05.006","type":"journal-article","created":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T02:40:49Z","timestamp":1557456049000},"page":"326.e1-326.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["A novel classification of residual disease after interval debulking surgery for advanced-stage ovarian cancer to better distinguish oncologic outcome"],"prefix":"10.1016","volume":"221","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5556-0457","authenticated-orcid":false,"given":"Beryl L.","family":"Manning-Geist","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Hicks-Courant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison A.","family":"Gockley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel M.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela G.","family":"Del Carmen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Whitfield B.","family":"Growdon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil S.","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ross S.","family":"Berkowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G.","family":"Muto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Michael J.","family":"Worley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2019.05.006_bib1","first-page":"1","article-title":"Carcinoma of the ovary","volume":"124","author":"Heintz","year":"2014","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.ajog.2019.05.006_bib2","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neo-adjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2019.05.006_bib3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(14)62223-6","article-title":"Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomized, controlled, non-inferiority trial","volume":"386","author":"Kehoe","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2019.05.006_bib4","article-title":"Phase III SCORPION trial (ID number: NCT01461850) in epithelial cancer patients with high tumor load receiving PDS versus NACT: an interim analysis on peri-operative outcome","author":"Fagotti","year":"2015","journal-title":"Proceedings Society of Gynecologic Oncology Annual Meeting on Women\u2019s Cancer"},{"key":"10.1016\/j.ajog.2019.05.006_bib5","doi-asserted-by":"crossref","first-page":"353s","DOI":"10.1200\/jco.2014.32.15_suppl.5508","article-title":"Comparison of treatment invasiveness between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III\/IV ovarian, tubal, and peritoneal cancers in phase III randomized trial: JCOG0602","volume":"32","author":"Onda","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2019.05.006_bib6","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/AOG.0b013e31822a6d56","article-title":"Thirty-day mortality after primary cytoreductive surgery for advanced ovarian cancer in the elderly","volume":"118","author":"Thrall","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.05.006_bib7","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1200\/JCO.2016.68.6907","article-title":"Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology clinical practice guideline","volume":"34","author":"Wright","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2019.05.006_bib8","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/IGC.0000000000001244","article-title":"Examining survival outcomes of 852 women with advanced ovarian cancer","volume":"28","author":"May","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ajog.2019.05.006_bib9","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ygyno.2014.07.004","article-title":"The impacts of neoadjuvant chemotherapy and of debulking surgery on survival from advanced ovarian cancer","volume":"134","author":"Rosen","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2019.05.006_bib10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejso.2008.01.005","article-title":"Aggressive surgical strategies in advanced ovarian cancer: a monocentric study of 203 stage IIIC and IV patients","volume":"35","author":"Colombo","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ajog.2019.05.006_bib11","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejogrb.2017.10.019","article-title":"Only complete tumour resection after neoadjuvant chemotherapy offers benefit over suboptimal debulking in advanced ovarian cancer","volume":"219","author":"Vermeulen","year":"2019","journal-title":"Eur J Obset Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2019.05.006_bib12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00404-015-3813-z","article-title":"Primary debulking surgery vs. neoadjuvant chemotherapy followed by interval debulking surgery in patients with advanced ovarian cancer","volume":"293","author":"Bian","year":"2016","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2019.05.006_bib13","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ygyno.2013.09.030","article-title":"Histopathology predicts clinical outcome in advanced epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and debulking surgery","volume":"131","author":"Muraji","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2019.05.006_bib14","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1245\/s10434-011-2100-x","article-title":"Primary debulking surgery versus neoadjuvant chemotherapy in stage IV ovarian cancer","volume":"19","author":"Rauh-Hain","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ajog.2019.05.006_bib15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ygyno.2018.06.015","article-title":"Moving beyond \u2018complete surgical resection\u2019 and \u2018optimal\u2019: is low-volume residual disease another option for primary debulking surgery","volume":"150","author":"Manning-Geist","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2019.05.006_bib16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ygyno.2008.10.008","article-title":"Aggressive and complex surgery for advanced ovarian cancer: an economic analysis","volume":"112","author":"Aletti","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2019.05.006_bib17","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1006\/gyno.2001.6328","article-title":"Identification of prognostic factors in advanced epithelial ovarian carcinoma","volume":"82","author":"Chi","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2019.05.006_bib18","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.ygyno.2006.06.025","article-title":"Platinum-based neoadjuvant chemotherapy and interval cytoreduction for advanced ovarian cancer: a metaanalysis","volume":"103","author":"Bristow","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2019.05.006_bib19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/gyno.2002.6849","article-title":"Quality of life in women treated with neoadjuvant chemotherapy for advanced ovarian cancer: a prospective longitudinal study","volume":"88","author":"Chan","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2019.05.006_bib20","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1245\/s10434-009-0558-6","article-title":"Does neoadjuvant chemotherapy increase optimal cytoreduction rate in advanced ovarian cancer? Meta-analysis of 21 studies","volume":"16","author":"Kang","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ajog.2019.05.006_bib21","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1245\/s10434-015-5051-9","article-title":"What should we expect after a complete cytoreduction at the time of interval or primary debulking surgery in advanced ovarian cancer?","volume":"23","author":"Chiva","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ajog.2019.05.006_bib22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ygyno.2009.03.018","article-title":"Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm","volume":"114","author":"Chi","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2019.05.006_bib23","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ygyno.2016.09.002","article-title":"Trends in the use of neoadjuvant chemotherapy for advanced ovarian cancer in the United States","volume":"143","author":"Melamed","year":"2016","journal-title":"Gynecol Oncol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937819306611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937819306611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:24:01Z","timestamp":1757589841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937819306611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0002937819306611"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2019.05.006","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel classification of residual disease after interval debulking surgery for advanced-stage ovarian cancer to better distinguish oncologic outcome","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2019.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}